We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$487M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$48.2M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$29.4M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$28.9M
5
MSFT icon
Microsoft
MSFT
+$27.7M

Top Sells

Rank Stock Value
1
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$51.8M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$38.5M
3
SOXL icon
Direxion Daily Semiconductor Bull 3X ETF
SOXL
+$32.6M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$21M
5
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$16.6M

Sector Composition

Rank Sector Weight
1 Technology 6.25%
2 Industrials 4.6%
3 Consumer Discretionary 4.31%
4 Healthcare 4.26%
5 Financials 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SUPV
4526
Grupo Supervielle
SUPV
$733M
$3K ﹤0.01%
1,525
+623
+69% +$1.58K
SYPR icon
4527
Sypris Solutions
SYPR
$48.1M
$3K ﹤0.01%
+2,257
New +$2.36K
TAYD icon
4528
Taylor Devices
TAYD
$172M
$3K ﹤0.01%
355
+60
+20% +$595
TGLS icon
4529
Tecnoglass Holdings Inc.
TGLS
$1.9B
$3K ﹤0.01%
517
+422
+444% +$2.25K
TTT icon
4530
ProShares UltraPro Short 20+ Year Treasury
TTT
$18.5M
$3K ﹤0.01%
100
-101
-50% -$2.78K
UGL icon
4531
ProShares Ultra Gold
UGL
$801M
$3K ﹤0.01%
156
-80
-34% -$1.44K
VRP icon
4532
Invesco Variable Rate Preferred ETF
VRP
$3.01B
$3K ﹤0.01%
124
– –
WHLRD
4533
Wheeler Real Estate Investment Trust Series D Preferred Stock
WHLRD
$63.8M
$3K ﹤0.01%
205
-395
-66% -$5.43K
ZDGE icon
4534
Zedge
ZDGE
$38.8M
$3K ﹤0.01%
2,354
-5,744
-71% -$8.46K
AIFC
4535
AI Financial Corp
AIFC
$58.7M
$3K ﹤0.01%
+710
New +$3.37K
QXO
4536
QXO Inc
QXO
$16.8B
$3K ﹤0.01%
153
-199
-57% -$4.57K
ONIT
4537
Onity Group
ONIT
$328M
$3K ﹤0.01%
140
-3,782
-96% -$68K
QCLS
4538
Q/C Technologies Inc
QCLS
$22.7M
– –
0
– –
HURA
4539
TuHURA Biosciences
HURA
$146M
$3K ﹤0.01%
+1
New +$2.01K
ACGN
4540
DELISTED
Aceragen Inc
ACGN
$3K ﹤0.01%
80
+29
+57% +$1.03K
APTO
4541
DELISTED
Aptose Biosciences, Inc.
APTO
$3K ﹤0.01%
1
-18
-95% -$44.9K
OPNT
4542
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
$3K ﹤0.01%
319
-3,408
-91% -$30.3K
PTNR
4543
DELISTED
Partner Communications
PTNR
$3K ﹤0.01%
668
-216
-24% -$863
AHPI
4544
DELISTED
Allied Healthcare Products
AHPI
$3K ﹤0.01%
+619
New +$5.24K
BTRS
4545
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
$3K ﹤0.01%
+300
New +$3.1K
IBMK
4546
DELISTED
iShares iBonds Dec 2022 Term Muni Bond ETF
IBMK
$3K ﹤0.01%
100
– –
STZ.B
4547
DELISTED
CONSTELLATION BRANDS, INC. CLASS B
STZ.B
$3K ﹤0.01%
16
+4
+33% +$724
USAK
4548
DELISTED
USA Truck Inc
USAK
$3K ﹤0.01%
+266
New +$2.71K
DISCB
4549
DELISTED
Discovery, Inc. Series B Common Stock
DISCB
$3K ﹤0.01%
95
-333
-78% -$12.4K
GFED
4550
DELISTED
Guaranty Federal Bancshares In
GFED
$3K ﹤0.01%
222
+201
+957% +$2.9K
180 181
182
183 184

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.